^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GIC-102

    i
    Other names: GIC-102
    Associations

    News

    Trials
    Company:
    GICELL
    Drug class:
    NK cell stimulant
    Related drugs:
    Associations

    News

    Trials
    6ms
    GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies (clinicaltrials.gov)
    P1/2, N=50, Recruiting, GI Cell, Inc. | Phase classification: P1 --> P1/2
    Phase classification • Metastases
    |
    GIC-102
    over1year
    A Study of GIC-102 (Allogeneic Natural Killer Cells) in Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, and Multiple Myeloma (clinicaltrials.gov)
    P1, N=9, Recruiting, GI Cell, Inc.
    New P1 trial • Metastases
    |
    cyclophosphamide • GIC-102